Growth hormone and bone

Endocrine Reviews

Volumn 19, Issue 1, 1998, Pages 55-79

  Ohlsson, Claes ^a,b   Bengtsson, Bengt Åke ^a   Isaksson, Olle G P ^a   Andreassen, Troels T ^c   Slootweg, Maria C ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; ESTROGEN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; MESSENGER RNA; OSTEOCALCIN; PROCOLLAGEN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; VITAMIN D;

ACROMEGALY; BONE GROWTH; BONE MASS; BONE METABOLISM; FRACTURE; FRACTURE HEALING; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; TRANSGENIC MOUSE;

EID: 0032468983     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.19.1.55     Document Type: Review

References (359)

1. Florini JR, Ewton DZ, Coolican SA 1996 Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17: 481-517
2. Feld S, Hirschberg R 1996 Growth hormone, the insulin-like growth factor system, and the kidney. Endocr Rev 17:423-480
3. Bouillon R 1991 Growth hormone and bone. Horm Res 36:49-55
4. Slootweg MC 1993 Growth hormone and bone. Horm Metab Res 25:335-343
5. Wuster C 1993 Growth hormone and bone metabolism. Acta Endocrinol (Copenh) 128:14-18
6. Eriksen EF, Kassem M, Brixen K 1993 Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis. Horm Res 40:95-98
7. Eriksen EF, Kassem M, Langdahl B 1996 Growth hormone, insulin-like growth factors and bone remodelling. Eur J Clin Invest 26:525-534
8. Harris WH, Heaney RP 1969 Effect of growth hormone on skeletal mass in adult dogs. Nature 223:403-404
9. Cheek D, Hill D 1974 Effect of growth hormone on cell and somatic growth. In: Knobil E, Sawyer W (eds) Handbook of Physiology. American Physiological Society, Washington DC, pp 159-185
10. Isaksson OG, Lindahl A, Nilsson A, Isgaard J 1987 Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8:426-438
11. Kember NF 1971 Cell population kinetics of bone growth: the first ten years of autoradiographic studies with tritiated thymidine. Clin Orthop 76:213-230
12. Kember NF 1978 Cell kinetics and the control of growth in long bones. Cell Tissue Kinet 11:477-485
13. Kember NF 1971 Growth hormone and cartilage cell division in hypophysectomized rats. Cell Tissue Kinet 4:193-199
14. Kember NF, Walker KV 1971 Control of bone growth in rats. Nature 229:428-429
15. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91
16. Daughaday WH, Hall K, Raben MS, Salmon Jr WD, Brande JL van den, Wyk JJ van 1972 Somatomedin: proposed designation for sulphation factor. Nature 235:107
17. Daughaday D 1981 Growth hormone and the somatomedins. In: Daughaday D (ed) Endocrine Control of Growth. Elsevier, New York, pp 1-24
18. Isaksson OG, Jansson JO, Gause IA 1982 Growth hormone stimulates longitudinal bone growth directly. Science 216:1237-1239
19. Barnard R, Ng KW, Martin TJ, Waters MJ 1991 Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 128:1459-1464
20. D'Ercole AJ, Stiles AD, Underwood LE 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935-939
21. Ernst M, Froesch ER 1988 Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochem Biophys Res Commun 151: 142-147
22. Isgaard J, Nilsson A, Lindahl A, Jansson JO, Isaksson OG 1986 Effects of local administration of GH and IGF-I on longitudinal bone growth in rats. Am J Physiol 250:E367-E372
23. Isgaard J, Nilsson A, Vikman K, Isaksson OG 1989 Growth hormone regulates the level of insulin-like growth factor-I mRNA in rat skeletal muscle. J Endocrinol 120:107-112
24. Kassem M, Blum W, Ristelli J, Mosekilde L, Eriksen EF 1993 Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 52: 222-226
25. Lewinson D, Shenzer P, Hochberg Z 1993 Growth hormone involvement in the regulation of tartrate-resistant acid phosphatase-positive cells that are active in cartilage and bone resorption. Calcif Tissue Int 52:216-221
26. Maor G, Hochberg Z, Silbermann M 1989 Growth hormone stimulates the growth of mouse neonatal condylar cartilage in vitro. Acta Endocrinol (Copenh) 120:526-532
27. Maor G, Hochberg Z, von der Mark K, Heinegard D, Silbermann M 1989 Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. Endocrinology 125:1239-1245
28. Nilsson A, Isgaard J, Lindahl A, Peterson L, Isaksson O 1987 Effects of unilateral arterial infusion of GH and IGF-I on tibial longitudinal bone growth in hypophysectomized rats. Calcif Tissue Int 40:91-96
29. Russell SM, Spencer EM 1985 Local injections of human or rat growth hormone or of purified human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats. Endocrinology 116:2563-2567
30. Schlechter NL, Russell SM, Greenberg S, Spencer EM, Nicoll CS 1986 A direct growth effect of growth hormone in rat hindlimb shown by arterial infusion. Am J Physiol 250:E231-E235
31. Schlechter NL, Russell SM, Spencer EM, Nicoll CS 1986 Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 83:7932-7934
32. Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, Duursma SA 1988 Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture. Acta Endocrinol (Copenh) 118:294-300
33. Stracke H, Schulz A, Moeller D, Rossol S, Schatz H 1984 Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture. Acta Endocrinol (Copenh) 107: 16-24
34. Vikman K, Carlsson B, Billig H, Eden S 1991 Expression and regulation of growth hormone (GH) receptor messenger ribonucleic acid (mRNA) in rat adipose tissue, adipocytes, and adipocyte precursor cells: GH regulation of GH receptor mRNA. Endocrinology 129:1155-1161
35. Green H, Morikawa M, Nixon T 1985 A dual effector theory of growth-hormone action. [Review]. Differentiation 29:195-198
36. Zezulak KM, Green H 1986 The generation of insulin-like growth factor-1-sensitive cells by growth hormone action. Science 233: 551-553
37. Isgaard J, Moller C, Isaksson OG, Nilsson A, Mathews LS, Norstedt G 1988 Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone. Endocrinology 122:1515-1520
38. Lindahl A, Isgaard J, Nilsson A, Isaksson OG 1986 Growth hormone potentiates colony formation of epiphyseal chondrocytes in suspension culture. Endocrinology 118:1843-1848
39. Lindahl A, Nilsson A, Isaksson OG 1987 Effects of growth hormone and insulin-like growth factor-I on colony formation of rabbit epiphyseal chondrocytes at different stages of maturation. J Endocrinol 115:263-271
40. Lindahl A, Isgaard J, Carlsson L, Isaksson OG 1987 Differential effects of growth hormone and insulin-like growth factor I on colony formation of epiphyseal chondrocytes in suspension culture in rats of different ages. Endocrinology 121:1061-1069
41. Lindahl A, Isgaard J, Isaksson OG 1987 Growth hormone in vivo potentiates the stimulatory effect of insulin-like growth factor-1 in vitro on colony formation of epiphyseal chondrocytes isolated from hypophysectomized rats. Endocrinology 121:1070-1075
42. Ohlsson C, Isaksson O, Lindahl A 1994 Clonal analysis of rat tibia growth plate chondrocytes in suspension culture-differential effects of growth hormone and insulin-like growth factor I. Growth Regul 4:1-7
43. Ohlsson C, Nilsson A, Isaksson O, Lindahl A 1992 Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate. Proc Natl Acad Sci USA 89:9826-9830
44. Hunziker EB, Wagner J, Zapf J 1994 Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J Clin Invest 93:1078-1086
45. Clark R, Carlsson L, Mortensen D, Cronin M 1994 Additive effects on body growth of insulin-like growth factor-1 and growth hormone in hypophysectomized rats. Endocrinol Metab 1:49-54
46. Guler HP, Zapf J, Scheiwiller E, Froesch ER 1988 Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 85:4889-4893
47. Holder AT, Spencer EM, Preece MA 1981 Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters in hypopituitary dwarf mice. J Endocrinol 89:275-282
48. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR 1993 Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 91:391-396
49. Laron Z, Anin S, Klipper-Aurbach Y, Klinger B 1992 Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 339: 1258-1261
50. Laron Z, Klinger B 1994 IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clin Endocrinol (Oxf) 41: 631-638
51. Ranke M, Savage M, Chatelain P, Preece M, Rosenfeld R, Blum W, Wilton P 1995 Insulin-like growth factor I improves height in growth hormone insensitivity: two years' result. Horm Res 44:253-264
52. Van den Brande JL, van Buul-Offers S 1979 Effect of growth hormone and peptide fractions containing somatomedin activity on growth and cartilage metabolism of Snell dwarfmice. Acta Endocrinol (Copenh) 92:242-257
53. Walker JL, Ginalska-Malinowska M, Romer TE, Pucilowska JB, Underwood LE 1991 Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism). N Engl J Med 324:1483-1488
54. Walker JL, Van Wyk JJ, Underwood LE 1992 Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type) [see comments]. J Pediatr 121:641-646
55. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82
56. LeRoith D 1996 Insulin-like growth factors and binding proteins. Baillieres Clin Endocrinol Metab 10:49-73
57. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
58. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617
59. Woods K, Camacho-Hubner C, Savage M, Clark A 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor gene. N Engl J Med 335:1363-1367
60. Clark R, Mortensen D, Carlsson L 1995 Insulin-like growth factor-1 and growth hormone (GH) have distinct and overlapping effects in GH-deficient rats. Endocrine 3:297-304
61. Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL, D'Ercole AJ 1990 Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 127:1033-1040
62. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD 1988 Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123:2827-2833
63. Fielder P, Mortensen D, Mallet P, Carlsson B, Baxter R, Clark R 1996 Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectormized rats. Endocrinology 137:1913-1920
64. Hazel SJ, Gillespie CM, Moore RJ, Clark RG, Jureidini KF, Martin AA 1994 Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. Kidney Int 46:58-68
65. Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM 1982 Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300:611-615
66. Behringer RR, Mathews LS, Palmiter RD, Brinster RL 1988 Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev 2:453-461
67. Ohlsson C, Isgaard J, Tornell J, Nilsson A, Isaksson OG, Lindahl A 1993 Endocrine regulation of longitudinal bone growth. Acta Paediatr Suppl 82:[Suppl 391]:33-40
68. Backeljauw PF, Underwood LE 1996 Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome-a clinical research center study. GHIS Collaborative Group. J Clin Endocrinol Metab 81:3312-3317
69. Guevara-Aguirre J, Vasconez O, Martinez V, Martinez AL, Rosenbloom AL, Diamond Jr FB, Gargosky SE, Nonoshita L, Rosenfeld RG 1995 A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab 80:1393-1398
70. Klinger B, Laron Z 1995 Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab 8:149-158
71. Walker JL, Baxter RC, Young S, Pucilowska J, Clemmons DR, Underwood LE 1993 Effects of recombinant insulin-like growth factor I on IGF binding proteins and the acid-labile subunit in growth hormone insensitivity syndrome. Growth Regul 3:109-112
72. Guevara-Aguirre J, Rosenbloom A, Vasconez O, Martinez V, Gargosky S, Allen L, Rosenfeld R 1997 Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. J Clin Endocrinol Metab 82:629-633
73. Ernst M, Rodan GA 1990 Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:807-814
74. Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, van der Meer JM, Duursma SA 1988 Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells. J Endocrinol 116:R11-R13
75. Scheven BA, Hamilton NJ, Fakkeldij TM, Duursma SA 1991 Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regul 1:160-167
76. Kassem M, Brixen K, Mosekilde L, Eriksen EF 1994 Human marrow stromal osteoblast-like cells do not show reduced responsiveness to in vitro stimulation with growth hormone in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:1-6
77. Kassem M, Mosekilde L, Eriksen EF 1994 Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. Growth Regul 4:131-135
78. Nilsson A, Swolin D, Enerback S, Ohlsson C 1995 Expression of functional growth hormone receptors in cultured human osteoblast-like cells. J Clin Endocrinol Metab 80:3483-3488
79. Salles JP, De Vries CP, Netelenbos JC, Slootweg MC 1994 Dexamethasone increases and serum decreases growth hormone receptor binding to UMR-106.01 rat osteosarcoma cells. Endocrinology 134:1455-1459
80. Morel G, Chavassieux P, Barenton B, Dubois PM, Meunier PJ, Boivin G 1993 Evidence for a direct effect of growth hormone on osteoblasts. Cell Tissue Res 273:279-286
81. Saggese G, Federico G, Cinquanta L 1993 In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells. Acta Paediatr Suppl 82:54-59
82. 3 and activity on human osteoblast-like cells in short-term cultures. Bone 11:81-86
83. Kanzaki S, Baxter RC, Knutsen R, Baylink DJ, Mohan S 1995 Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. J Bone Miner Res 10:854-858
84. Slootweg MC, Hoogerbrugge CM, de Poorter TL, Duursma SA, van Buul-Offers SC 1990 The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs? J Endocrinol 125:271-277
85. Okazaki R, Conover CA, Harris SA, Spelsberg TC, Riggs BL 1995 Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not. J Bone Miner Res 10:788-795
86. Swolin D, Brantsing C, Matejka G, Ohlsson C 1996 Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells. J Endocrinol 149:397-403
87. Slootweg MC, van Buul-Offers SC, Hoogerbrugge CM, Herrmann-Erlee MP, van den Eijnden-van Raaij AJ, Duursma SA, van Zoelen EJ1990 Characterization of growth factor activity produced by fetal mouse osteoblasts. J Endocrinol 124:301-309
88. Canalis E, Centrella M, Burch W, McCarthy TL 1989 Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60-65
89. Mohan S, Baylink DJ 1991 Bone growth factors. Clin Orthop 263: 30-48
90. Wong GL, Kotliar D, Schlaeger D, Brandes SJ 1990 IGF-I production by mouse osteoblasts. J Bone Miner Res 5:133-140
91. Okazaki R, Durham SK, Riggs BL, Conover CA 1995 Transforming growth factor-beta and forskolin increase all classes of insulin-like growth factor-I transcripts in normal human osteoblast-like cells. Biochem Biophys Res Commun 207:963-970
92. Strom P, Ljunghall S, Melhus H1994 Adult human osteoblast-like cells do not express insulin-like growth factor-I. Biochem Biophys Res Commun 199:78-82
93. Middleton J, Arnott N, Walsh S, Beresford J 1995 Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. Bone 16:287-293
94. Canalis E, Gabbitas B 1994 Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures. J Bone Miner Res 9:1999-2005
95. Delany AM, Canalis E 1995 Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells. Endocrinology 136:4776-4781
96. McCarthy TL, Casinghino S, Centrella M, Canalis E 1994 Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. J Cell Physiol 160:163-175
97. McCarthy TL, Centrella M, Canalis E 1989 Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124:1247-1253
98. McCarthy TL, Centrella M, Canalis E 1990 Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. Endocrinology 126:1569-1575
99. McCarthy TL, Centrella M, Raisz LG, Canalis E 1991 Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 128: 2895-2900
100. Pash JM, Delany AM, Adamo ML, Roberts Jr CT, LeRoith D, Canalis E 1995 Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells. Endocrinology 136: 33-38
101. Ernst M, Heath JK, Rodan GA 1989 Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825-833
102. Ernst M, Rodan GA 1991 Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 5:1081-1089
103. Hayden JM, Mohan S, Baylink DJ 1995 The insulin-like growth factor system and the coupling of formation to resorption. Bone 17:93S-98S
104. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70:1292-1298
105. Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, Marcus R 1994 Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 79:1361-1366
106. Mandel S, Moreland E, Nichols V, Hanna C, Lafranchi S 1995 Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment. J Clin Endocrinol Metab 80:190-194
107. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 79:470-479
108. Mohan S, Baylink DJ, Pettis JL 1996 Insulin-like growth factor (IGF)-binding proteins in serum-do they have additional roles besides modulating the endocrine IGF actions? J Clin Endocrinol Metab 81:3817-3820
109. Ono T, Kanzaki S, Seino Y, Baylink DJ, Mohan S 1996 Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme. J Clin Endocrinol Metab 81:2111-2116
110. Bagi CM, DeLeon E, Brommage R, Adams S, Rosen D, Sommer A 1995 Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats. Bone 16:2635-2695
111. Schmid C, Ernst M, Zapf J, Froesch ER 1989 Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. Biochem Biophys Res Commun 160: 788-794
112. Schmid C, Schlapfer I, Peter M, Boni-Schnetzler M, Schwander J, Zapf J, Froesch ER 1994 Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. Am J Physiol 267:E226-E233
113. Mohan S, Strong DD, Lempert UG, Tremollieres F, Wergedal JE, Baylink DJ 1992 Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells. Acta Endocrinol (Copenh) 127:555-564
114. Mohan S, Bautista CM, Wergedal J, Baylink DJ 1989 Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. Proc Natl Acad Sci USA 86:8338-8342
115. Bautista CM, Baylink DJ, Mohan S 1991 Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 176:756-763
116. Andress DL, Birnbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22467-22472
117. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ 1995 Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270:20424-20431
118. Chen TL, Liu F, Bates RL, Hintz RL 1991 Further characterization of insulin-like-growth factor binding proteins in rat osteoblast-like cell cultures: modulation by 17 beta-estradiol and human growth hormone. Endocrinology 128:2489-2496
119. Durham SK, Riggs BL, Conover CA 1994 The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta. J Clin Endocrinol Metab 79:1752-1758
120. Slootweg MC, van Genesen ST, Otte AP, Duursma SA, Kruijer W 1990 Activation of mouse osteoblast growth hormone receptor: c-fos oncogene expression independent of phosphoinositide breakdown and cyclic AMP. J Mol Endocrinol 4:265-274
121. Melhus H, Ljunghall S 1996 Growth hormone and insulin-like growth factor-I do not activate identical genes in normal human osteoblasts. Biochem Mol Biol Int 38:425-428
122. Slootweg MC, Salles JP, Ohlsson C, de Vries CP, Engelbregt MJ, Netelenbos JC 1996 Growth hormone binds to a single high affinity receptor site on mouse osteoblasts: modulation by retinoic acid and cell differentiation. J Endocrinol 150:465-472
123. Slootweg MC, Ohlsson C, Salles JP, de Vries CP, Netelenbos JC 1995 Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Endocrinology 136:4210-4217
124. Slootweg M, Ohlsson C, van Elk E, Netelenbos J, Andress D 1996 Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells. Growth Regul 6:238-246
125. Leung K, Rajkovic IA, Peters E, Markus I, Van Wyk JJ, Ho KK 1996 Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: evidence for a peripheral feedback loop regulating GH action. Endocrinology 137:2694-2702
126. Ohlsson C, Lovstedt K, Holmes PV, Nilsson A, Carlsson L, Tornell J 1993 Embryonic stem cells express growth hormone receptors: regulation by retinoic acid. Endocrinology 133:2897-2903
127. Slootweg M, Swolin D, Netelenbos J, Isaksson O, Ohlsson C 1997 Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells. J Endocrinol 155:159-164
128. Swolin D, Nilsson A, Ohlsson C 1998 Cortisol increases growth hormone receptor expression in human osteoblast-like cells. J Endocrinol 156:99-105
129. Kelly PA, Ali S, Rozakis M, Goujon L, Nagano M, Pellegrini I, Gould D, Djiane J, Edery M, Finidori J, et al. 1993 The growth hormone/prolactin receptor family. Recent Prog Horm Res 48:123-164
130. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C 1993 Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244
131. Carter-Su C, Argetsinger LS, Campbell GS, Wang X, Ihle J, Witthuhn B 1994 The identification of JAK2 tyrosine kinase as a signaling molecule for growth hormone. Proc Soc Exp Biol Med 206:210-215
132. Stred SE, Stubbart JR, Argetsinger LS, Smith WC, Shafer JA, Talamantes F, Carter-Su C 1992 Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity. Endocrinology 130:1626-1636
133. Campbell GS, Meyer DJ, Raz R, Levy DE, Schwartz J, Carter-Su C 1995 Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. J Biol Chem 270:3974-3979
134. Meyer DJ, Campbell GS, Cochran BH, Argetsinger LS, Lamer AC, Finbloom DS, Carter-Su C, Schwartz J 1994 Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor. J Biol Chem 269:4701-4704
135. Gronowski AM, Zhong Z, Wen Z, Thomas MJ, Darnell Jr JE, Rotwein P 1995 In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3. Mol Endocrinol 9:171-177
136. Moller C, Hansson A, Enberg B, Lobie PE, Norstedt G 1992 Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. J Biol Chem 267:23403-23408
137. Campbell GS, Pang L, Miyasaka T, Saltiel AR, Carter-Su C 1992 Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. J Biol Chem 267:6074-6080
138. Souza SC, Frick GP, Yip R, Lobo RB, Tai LR, Goodman HM 1994 Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. J Biol Chem 269:30085-30088
139. Argetsinger LS, Hsu GW, Myers Jr MG, Billestrup N, White MF, Carter-Su C 1995 Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem 270:14685-14692
140. Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C 1996 Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem 271:29415-29421
141. Slootweg MC, de Groot RP, Herrmann-Erlee MP, Koornneef I, Kruijer W, Kramer YM 1991 Growth hormone induces expression of c-jun and jun B oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos oncogene expression. J Mol Endocrinol 6:179-188
142. Salles JP, Netelenbos JC, Slootweg MC 1996 Growth hormone induces tyrosine phosphorylation of annexin I in rat osteosarcoma cells. Endocrinology 137:4358-4362
143. Raynal P, Pollard HB 1994 Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197:63-93
144. Ransjö M, Lerner U, Ohlsson C 1996 Growth hormone inhibits formation of osteoclast-like cells in mouse bone marrow cultures. J Bone Miner Res 11 [Suppl]:T394
145. Nishiyama K, Sugimoto T, Kaji H, Kanatani M, Kobayashi T, Chihara K 1996 Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology 137:35-41
146. Slootweg MC, Most WW, van Beek E, Schot LP, Papapoulos SE, Lowik CW 1992 Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. J Endocrinol 132:433-438
147. Saggese G, Baroncelli GI, Federico G, Bertelloni S 1995 Effects of growth hormone on phosphocalcium homeostasis and bone me-tabolism. Horm Res 44:55-63
148. Swolin D, Ohlsson C 1996 Growth hormone increases interleukin-6 produced by human osteoblast-like cells. J Clin Endocrinol Metab 81:4329-4333
149. Mochizuki H, Hakeda Y, Wakatsuki N, Usui N, Akashi S, Sato T, Tanaka K, Kumegawa M 1992 Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 131: 1075-1080
150. Hill PA, Reynolds JJ, Meikle MC 1995 Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 136:124-131
151. Fiorelli G, Formigli L, Zecchi Orlandini S, Gori F, Falchetti A, Morelli A, Tanini A, Benvenuti S, Brandi ML 1996 Characterization and function of the receptor for IGF-I in human preosteoclastic cells. Bone 18:269-276
152. Klindt J, Buonomo FC, Wise T, Yen JT 1996 Endocrine and metabolite responses to porcine growth hormone administered by sustained release implant for different lengths of time in male pigs. Endocrinology 137:3689-3695
153. Goff JP, Caperna TJ, Steele NC 1990 Effects of growth hormone administration on vitamin D metabolism and vitamin D receptors in the pig. Domest Anim Endocrinol 7:425-433
154. Lobie PE, Garcia-Aragon J, Wang BS, Baumbach WR, Waters MJ 1992 Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130:3057-3065
155. Hedner E, Linde A, Nilsson A 1996 Systemically and locally administered growth hormone stimulates bone healing in combination with osteopromotive membranes: an experimental study in rats. J Bone Miner Res 11:1952-1960
156. Saban J, Schneider GB, Bolt D, King D 1996 Erythroid-specific expression of human growth hormone affects bone morphology in transgenic mice. Bone 18:47-52
157. Tseng KF, Bonadio JF, Stewart TA, Baker AR, Goldstein SA 1996 Local expression of human growth hormone in bone results in impaired mechanical integrity in the skeletal tissue of transgenic mice. J Orthop Res 14:598-604
158. Baker AR, Hollingshead PG, Pitts-Meek S, Hansen S, Taylor R, Stewart TA 1992 Osteoblast-specific expression of growth hormone stimulates bone growth in transgenic mice. Mol Cell Biol 12:5541-5547
159. Hock JM, Fonseca J 1990 Anabolic effect of human synthetic parathyroid hormone-(l-34) depends on growth hormone. Endocrinology 127:1804-1810
160. Chen MM, Yeh JK, Aloia JF 1995 Effect of ovariectomy on cancellous bone in the hypophysectomized rat. J Bone Miner Res 10:1334-1342
161. Schmidt IU, Dobnig H, Turner RT 1995 Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. Endocrinology 136:5127-5134
162. Yeh JK, Chen MM, Aloia JF 1995 Skeletal alterations in hypophysectomized rats. I. A histomorphometric study on tibial cancellous bone. Anat Rec 241:505-512
163. Bikle DD, Harris J, Halloran BP, Currier PA, Tanner S, Morey-Holton E 1995 The molecular response of bone to growth hormone during skeletal unloading: regional differences. Endocrinology 136: 2099-2109
164. Halloran BP, Bikle DD, Harris J, Autry CP, Currier PA, Tanner S, Patterson-Buckendahl P, Morey-Holton E 1995 Skeletal unloading induces selective resistance to the anabolic actions of growth hormone on bone. J Bone Miner Res 10:1168-1176
165. Schiltz PM, Ohta T, Glass D, Mohan S, Baylink DJ 1992 Growth hormone stimulates cortical bone formation in immature hypophysectomized rats. Endocr Res 18:19-30
166. Charlton HM, Clark RG, Robinson IC, Goff AE, Cox BS, Bugnon C, Bloch BA 1988 Growth hormone-deficient dwarfism in the rat: a new mutation. J Endocrinol 119:51-58
167. Bartlett JM, Charlton HM, Robinson IC, Nieschlag E 1990 Pubertal development and testicular function in the male growth hormone-deficient rat. J Endocrinol 126:193-201
168. Gevers EF, Wit JM, Robinson IC 1995 Effect of gonadectomy on growth and GH responsiveness in dwarf rats. J Endocrinol 145: 69-79
169. Wright NM, Renault J, Hollis B, Bell NH, Key LL 1995 Effect of growth hormone on bone: bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone. J Bone Miner Res 10:127-131
170. Martinez DA, Orth MW, Carr KE, Vanderby Jr R, Vailas AC 1996 Cortical bone growth and maturational changes in dwarf rats induced by recombinant human growth hormone. Am J Physiol 270:E51-E59
171. Kimmel D 1991 Quantitative histologic changes in the proximal tibial growth cartilage of aged female rats. Cells and Materials [Suppl 1]:11-18
172. Baron R, Tross R, Vignery A 1984 Evidence of sequential remodeling in rat trabecular bone: morphology, dynamic histomorphometry, and changes during skeletal maturation. Anat Rec 208:137-145
173. Erben RG 1996 Trabecular and endocortical bone surfaces in the rat: modeling or remodeling? Anat Rec 246:39-46
174. Aspenberg P, Hansson LI, Thorngren KG 1985 Modification of bone formation rate by growth hormone, melanocyte-stimulating hormone, and cortisone in the normal rat. Acta Anat (Basel) 121: 84-88
175. Jorgensen PH, Bak B, Andreassen TT 1991 Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone. Bone 12:353-359
176. Andreassen TT, Jorgensen PH, Flyvbjerg A, Orskov H, Oxlund H 1995 Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 10:1057-1067
177. Turner CH, Burr DB 1993 Basic biomechanical measurements of bone: a tutorial. Bone 14:595-608
178. Andreassen TT, Melsen F, Oxlund H 1996 The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats. J Bone Miner Res 11:1094-1102
179. Ortoft G, Oxlund H 1996 Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid. Bone 18:581-590
180. Turner RT 1995 Effects of short-term spaceflight and recombinant human growth hormone (rhGH) on bone growth in young rats. Aviat Space Environ Med 66:763-769
181. Yeh JK, Aloia JF, Chen M, Ling N, Koo HC, Millard WJ 1994 Effect of growth hormone administration and treadmill exercise on serum and skeletal IGF-I in rats. Am J Physiol 266:E129-E135
182. Oxlund H, Ejersted C, Andreassen T 1996 Growth hormone increases the collagen deposition rate of cancellous bone in old rats. Bone [Suppl 3] 19:1575
183. Aer J, Halme J, Kivirikko KI, Laitinen O 1968 Action of growth hormone on the metabolism of collagen in the rat. Biochem Pharmacol 17:1173-1180
184. Pilegaard R, Oxlund H, Ortoft G, Andreassen T 1997 Direct determination of bone resorption in vivo: growth homone increases the excretion of 3H-tetracycline from prelabelled rats. Endocrinol Metab [Suppl A]4:37
185. Ejersted C, Andreassen TT, Hauge EM, Meisen F, Oxlund H 1995 Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone 17:507-511
186. Ejersted C, Andreassen TT, Nilsson MH, Oxlund H 1994 Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats. Eur J Endocrinol 130:201-207
187. Andreassen T, Oxlund H 1996 Additive anabolic effects of growth hormone and parathyroid hormone on vertebral body cortical and cancellous bone in old ovariectomized rats. J Bone Miner Res [Suppl 1]11:S457
188. Wanke R, Wolf E, Hermanns W, Folger S, Buchmuller T, Brem G 1992 The GH-transgenic mouse as an experimental model for growth research: clinical and pathological studies. Horm Res 37: 74-87
189. Wolf E, Rapp K, Brem G 1991 Expression of metallothionein-human growth hormone fusion genes in transgenic mice results in disproportionate skeletal gigantism. Growth Dev Aging 55:117-127
190. Wolf E, Rapp K, Wanke R, Hermanns W, Pirchner F, von Butler-Wemken I, Brem G 1991 Growth characteristics of metallothionein-human growth hormone transgenic mice as compared to mice selected for high eight-week body weight and unselected controls. II. Skeleton. Growth Dev Aging 55:237-248
191. Sandstedt J, Ohlsson C, Norjavaara E, Nilsson J, Tornell J 1994 Disproportional bone growth and reduced weight gain in gonadectomized male bovine growth hormone transgenic and normal mice. Endocrinology 135:2574-2580
192. Sandstedt J, Törnell J, Norjavaara E, Isaksson O, Ohlsson C 1996 Intact testis function is a prerequisite for an optimal effect of elevated GH levels on vertebral bone weight in mice. Endocrinol Metab [Suppl 1A]4:10
193. Sandstedt J, Tornell J, Norjavaara E, Isaksson OG, Ohlsson C 1996 Elevated levels of growth hormone increase bone mineral content in normal young mice, but not in ovariectomized mice. Endocrinology 137:3368-3374
194. Ohlsson C, Tornell J, Sandstedt J, Anderassen TT 1996 Effect of increased growth hormone on mechanical strength of cortical bone in growth hormone-transgenic mice. J Bone Miner Res [Suppl 1]11: S458
195. Mann DR, Rudman CG, Akinbami MA, Gould KG 1992 Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration. J Clin Endocrinol Metab 74:1263-1269
196. Sass DA, Jerome CP, Bowman AR, Bennett-Cain A, Ginn TA, LeRoith D, Epstein S 1997 Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone formation in Rhesus Macaque monkeys. J Clin Endocrinol Metab 82:1202-1209
197. Kalu DN 1984 Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. Endocrinology 115:507-512
198. Wronski TJ, Dann LM, Horner SL 1989 Time course of vertebral osteopenia in ovariectomized rats. Bone 10:295-301
199. Li M, Shen Y, Wronski TJ 1997 Time course of femoral neck osteopenia in ovariectomized rats. Bone 20:55-61
200. Turner RT, Vandersteenhoven JJ, Bell NH 1987 The effects of ovariectomy and 17 beta-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2:115-122
201. Danielsen CC, Flyvbjerg A 1996 Insulin-like growth factor I as a predictor of cortical bone mass in a long-term study of ovariectomized and estrogen-treated rats. Bone 19:493-498
202. Danielsen CC, Mosekilde L, Svenstrup B 1993 Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution. Calcif Tissue Int 52:26-33
203. Kalu DN 1991 The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-191
204. Frost HM, Jee WS 1992 On the rat model of human osteopenias and osteoporoses. Bone Miner 18:227-236
205. Sims NA, Morris HA, Moore RJ, Durbridge TC 1996 Increased bone resorption precedes increased bone formation in the ovariectomized rat. Calcif Tissue Int 59:121-127
206. Nowak J, Nygaard H, Eschen C 1995 Growth hormone and/or estradiol and gestagen as a treatment of osteoporosis in the aged ovariectomized rat. J Bone Miner Res [Suppl 1]10:S252
207. Noland K, Orhii P, Rutstein J, Kalu D 1996 Effect of growth hormone therapy on cortical bone in aged ovariectomized rats. J Bone Miner Res [Suppl 1]11:S458
208. Orhii P, Noland K, Rutstein J, Kalu D 1996 Effect of growth hormone therapy on cancellous bone in aged ovariectomized rats. J Bone Miner Res [Suppl 1]11:S458
209. Verhaeghe J, van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J Mosekilde L, Einhorn TA, Bouillon R 1996 Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats. J Bone Miner Res 11:1723-1735
210. Eschen C, Andreassen TT 1995 Growth hormone normalizes vertebral strength in ovariectomized rats. Calcif Tissue Int 57:392-396
211. Turner RT, Hannon KS, Greene VS, Bell NH 1995 Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats. Calcif Tissue Int 56:311-315
212. Jee WS, Blackwood EL, Dockum NL, Haslam RK, Kincl FA 1966 Bio-assay of responses of growing bones to cortisol. Clin Orthop 49:39-63
213. Jett S, Wu K, Duncan H, Frost HM 1970 Adrenalcorticosteroid and salicylate actions on human and canine haversian bone formation and resorption. Clin Orthop 68:301-315
214. Quarles LD 1992 Prednisone-induced osteopenia in beagles: variable effects mediated by differential suppression of bone formation. Am J Physiol 263:E136-E141
215. King CS, Weir EC, Gundberg CW, Fox J, Insogna KL 1996 Effects of continuous glucocorticoid infusion on bone metabolism in the rat. Calcif Tissue Int 59:184-191
216. Ferretti JL, Vazquez SO, Delgado CJ, Capozza R, Cointry G 1992 Biphasic dose-response curves of cortisol effects on rat diaphyseal bone biomechanics. Calcif Tissue Int 50:49-54
217. Ortoft G, Oxlund H 1988 Reduced strength of rat cortical bone after glucocorticoid treatment. Calcif Tissue Int 43:376-382
218. Altman A, Hochberg Z, Silbermann M 1992 Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse. Calcif Tissue Int 51:298-304
219. Sanchez CP, Goodman WG, Brandli D, Goldenhersh M, Murray C, Carlton E, Hahn T, Salusky IB 1995 Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids. J Bone Miner Res 10:2-6
220. Kovacs G, Fine RN, Worgall S, Schaefer F, Hunziker EB, Skottner-Lindun A, Mehls O 1991 Growth hormone prevents steroid-induced growth depression in health and uremia. Kidney Int 40:1032-1040
221. Ortoft G, Oxlund H, Jorgensen PH, Andreassen TT 1992 Glucocorticoid treatment or food deprivation counteract the stimulating effect of growth hormone on rat cortical bone strength. Acta Paediatr 81:912-917
222. Joyce ME, Terek RM, Jingushi S, Bolander ME 1990 Role of transforming growth factor-beta in fracture repair. Ann NY Acad Sci 593:107-123
223. Ashhurst D 1992 Macromolecular synthesis and mechanical stability during fracture repair. In: Hall B (ed) Fracture Repair and Regeneration. CRC Press Inc, Boca Raton, FL, pp 61-121
224. Koskinen E 1959 The repair of experimental fractures under the action of growth hormone, thyrotropin and cortisone. A tissue analytic, roentgenologic and autoradiographic study. Ann Chir Gynaecol [Suppl]90:1-48
225. Udupa K, Gupta L 1965 The effect of growth hormone and thyroxin in healing of fractures. Indian J Med Res 53:623-628
226. Muhlbach R, Tarsoly E, Trzenschik K, Hirthe D 1972 Effect of growth hormone on the metabolism of bones and the healing of fractures. Acta Chir Acad Sci Hung 13:51-63
227. Zilkens KW, Senk G, Bubenzer J, Peters H 1980 The influence of growth hormone in healing of fractures in rats (author's transl). Unfallheilkunde 83:446-449
228. Pak J, Donovan J, Meier S, Schmelng G 1991 Effects of growth hormone and levodopa on fracture healing: a rat model. J Orthop Res 9:383
229. Bak B, Jorgensen PH, Andreassen TT 1990 Dose response of growth hormone on fracture healing in the rat. Acta Orthop Scand 61:54-57
230. Bak B, Jorgensen PH, Andreassen TT 1991 The stimulating effect of growth hormone on fracture healing is dependent on onset and duration of administration. Clin Orthop 264:295-301
231. Nielsen HM, Bak B, Jorgensen PH, Andreassen TT 1991 Growth hormone promotes healing of tibial fractures in the rat. Acta Orthop Scand 62:244-247
232. Bak B, Andreassen TT 1989 The effect of aging on fracture healing in the rat. Calcif Tissue Int 45:292-297
233. Bak B, Andreassen TT 1991 The effect of growth hormone on fracture healing in old rats. Bone 12:151-154
234. Herold HZ, Hurvitz A, Tadmor A 1971 The effect of growth hormone on the healing of experimental bone defects. Acta Orthop Scand 42:377-384
235. Northmore-Ball M, Wood M, Meggit B 1980 A biomechanical study of the effects of growth hormone in experimental fracture healing. J Bone Joint Surg [Br] 62:391-396
236. Aspenberg P, Wang JS, Choong P, Thorngren KG 1994 No effect of growth hormone on bone graft incorporation. Titanium chamber study in the normal rat. Acta Orthop Scand 65:456-461
237. Harris J, Bean DA, Banks HH 1975 Effect of phosphate supplementation, thyrocalcitonin, and growth hormone on strength of fracture healing. Surg Forum 26:519-521
238. Wittbjer J, Aspenberg P, Thorngren KG 1985 Composite grafts of demineralized compact bone and marrow under systemic biosynthetic growth hormone treatment. Arch Orthop Trauma Surg 104: 233-237
239. Carpenter JE, Hipp JA, Gerhart TN, Rudman CG, Hayes WC, Trippel SB 1992 Failure of growth hormone to alter the biomechanics of fracture-healing in a rabbit model. J Bone Joint Surg [Am] 74:359-367
240. Ehrnberg A, Brosjo O, Laftman P, Nilsson O, Stromberg L 1993 Enhancement of bone formation in rabbits by recombinant human growth hormone. Acta Orthop Scand 64:562-566
241. Zadek R, Robinson R 1961 The effect of growth hormone on experimental long-bone defects. J Bone Joint Surg [Am] 43:1261
242. Dubreuil P, Abribat T, Broxup B, Brazeau P 1996 Long-term growth hormone-releasing factor administration on growth hormone, insulin-like growth factor-I concentrations, and bone healing in the Beagle. Can J Vet Res 60:7-13
243. Koskinen E 1963 The effect of growth hormone and thyreotropin on human fracture healing. A clinical, quantitative radiographic and metabolic study. Acta Orthop Scand [Suppl]62:1-68
244. Koskinen E, Lindholm R, Nieminen R, Puranen J, Attila U 1978 Human growth hormone in delayed union and non-union of fractures. Int Orthop 1:317-322
245. de la Piedra C, Larranaga J, Castro N, Horcajada C, Rapado A, Herrera Pombo JL, Carbo E 1988 Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly. Calcif Tissue Int 43:44-45
246. Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR 1993 Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76:1452-1457
247. Halse J, Gordeladze JO 1978 Urinary hydroxyproline excretion in acromegaly. Acta Endocrinol (Copenh) 89:483-491
248. Halse J, Gordeladze JO 1981 Total and non-dialyzable urinary hydroxyproline in acromegalics and control subjects. Acta Endocrinol (Copenh) 96:451-457
249. Halse J, Melsen F, Mosekilde L 1981 Iliac crest bone mass and remodelling in acromegaly. Acta Endocrinol (Copenh) 97:18-22
250. Hampel R, Rose HJ, Jahreis G, Krabbe S, Meng W, Hesse V 1990 Bone alkaline phosphatase as an activity parameter of acromegaly. Dtsch Med Wochenschr 115:363-366
251. Kotzmann H, Bernecker P, Hubsch P, Pietschmann P, Woloszczuk W, Svoboda T, Geyer G, Luger A 1993 Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 8:459-465
252. Marazuela M, Astigarraga B, Tabuenca MJ, Estrada J, Marin F, Lucas T 1993 Serum bone G1a protein as a marker of bone turnover in acromegaly. Calcif Tissue Int 52:419-421
253. Bijlsma JW, Nortier JW, Duursma SA, Croughs RJ, Bosch R, Thijssen JH 1983 Changes in bone metabolism during treatment of acromegaly. Acta Endocrinol (Copenh) 104:153-159
254. Terzolo M, Piovesan A, Osella G, Pia A, Reimondo G, Pozzi C, Raucci C, Torta M, Paccotti P, Angeli A 1993 Serum levels of bone G1a protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment. Calcif Tissue Int 52:188-191
255. Diamond T, Nery L, Posen S 1989 Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 111:567-573
256. Albright F, Reifenstein EC 1948 The Parathyroid Glands and Metabolic Bone Disease. Williams & Wilkins, Baltimore
257. Riggs BL, Randall RV, Wahner HW, Jowsey J, Kelly PJ, Singh M 1972 The nature of the metabolic bone disorder in acromegaly. J Clin Endocrinol Metab 34:911-918
258. Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL 1982 Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 69:1302-1309
259. Ho PJ, Fig LM, Barkan AL, Shapiro B 1992 Bone mineral density of the axial skeleton in acromegaly. J Nucl Med 33:1608-1612
260. Roelfsema F, Sluys J van der, Smeenk D 1970 Quantitation of bone and bone turnover in biopsy specimens from the iliac crest in acromegaly. J Endocrinol 48:LXI
261. Aloia JF, Roginsky MS, Jowsey J, Dombrowski CS, Shukla KK, Cohn SH 1972 Skeletal metabolism and body composition in acromegaly. J Clin Endocrinol Metab 35:543-551
262. Hubsch P, Kotzmann H, Svoboda T, Kainberger FM, Bankier A, Seidl G 1993 Bone density of the lumbar spine and femur in acromegaly. Radiologe 33:457-461
263. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM 1995 Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin Endocrinol (Oxf) 42:627-633
264. Sartorio A, Conti A, Monzani M, Morabito F, Faglia G 1993 Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover. J Endocrinol Invest 16:893-898
265. Delmas PD, Chatelain P, Malaval L, Bonne G 1986 Serum bone GLA-protein in growth hormone deficient children. J Bone Miner Res 1:333-338
266. Nielsen HK, Jorgensen JO, Brixen K, Christiansen JS 1991 Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH. Calcif Tissue Int 48:82-87
267. Nielsen HK, Jorgensen JO, Brixen K, Moller N, Charles P, Christensen JS 1991 24-h profile of serum osteocalcin in growth hormone (GH) deficient patients with and without GH treatment. Growth Regul 1:153-159
268. Balducci R, Toscano V, Pasquino AM, Mangiantini A, Municchi G, Armenise P, Terracina S, Prossomariti G, Boscherini B 1995 Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. Eur J Endocrinol 132:42-46
269. Johansen JS, Pedersen SA, Jorgensen JO, Riis BJ, Christiansen C, Christiansen JS, Skakkebaek NE 1990 Effects of growth hormone (GH) on plasma bone G1a protein in GH-deficient adults. J Clin Endocrinol Metab 70:916-919
270. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JO, Hassager C, Christiansen C 1991 The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol (Oxf) 35:471-476
271. Ferrandez A, Zachmann M, Prader A, Illig R 1970 Isolated growth hormone deficiency in prepubertal children. Influence of human growth hormone on longitudinal growth, adipose tissue, bone mass and bone maturation. Helv Paediatr Acta 25:566-576
272. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ 1980 Bone mineral status in growth hormone deficiency. J Pediatr 96: 393-396
273. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 74:118-123
274. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76:1344-1348
275. de Boer H, Blok GJ, van Lingen A, Teule GJ, Lips P, van der Veen EA 1994 Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 9:1319-1326
276. Nussey SS, Hyer SL, Brada M, Leiper AD, Pazianas M 1994 Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatr Suppl 399:9-14
277. Bravenboer N, Holzmann P, de Boer H, Blok GJ, Lips P 1996 Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men. Bone 18:551-557
278. Sartorio A, Ortolani S, Conti A, Cherubini R, Galbiati E, Faglia G 1996 Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency. J Endocrinol Invest 19: 524-529
279. Amato G, Izzo G, La Montagna G, Bellastella A 1996 Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects. Clin Endocrinol (Oxf) 45:27-32
280. Hyer SL, Rodin DA, Tobias JH, Leiper A, Nussey SS 1992 Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child 67:1472-1474
281. Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A 1992 Osteopenia in men with a history of delayed puberty. N Engl J Med 326:600-604
282. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S 1996 The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 81:3077-3083
283. Wuster C, Slenczka E, Ziegler R 1991 Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution? Klin Wochenschr 69:769-773
284. Johansson AG, Burman P, Westermark K, Ljunghall S 1992 The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 232:447-452
285. Bing-You RG, Denis MC, Rosen CJ 1993 Low bone mineral density in adults with previous hypothalamic-pituitary tumors: correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3. Calcif Tissue Int 52:183-187
286. Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson BA 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:201-206
287. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78:669-674
288. Beshyah SA, Freemantle C, Thomas E, Rutherford O, Page B, Murphy M, Johnston DG 1995 Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf) 42:179-189
289. Degerblad M, Bengtsson BA, Bramnert M, Johnell O, Manhem P, Rosen T, Thoren M 1995 Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy. Eur J Endocrinol 133:180-188
290. Kaji H, Abe H, Fukase M, Chihara K 1997 Normal bone mineral density in patients with adult onset GH deficiency. Endocrinol Metab 4:163-166
291. Toogood AA, Adams JE, O'Neill PA, Shalet SM 1997 Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab 82:1462-1466
292. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA 1997 Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137: 240-245
293. Ott SM 1990 Attainment of peak bone mass. J Clin Endocrinol Metab 71:1082A-1082C
294. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Sacca L, Bellastella A 1993 Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 77:1671-1676
295. Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A 1996 Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 125:883-890
296. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OG 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317
297. Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG 1994 The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol (Oxf) 40:383-391
298. Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG 1995 The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol (Oxf) 42:249-254
299. Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, Lamberts SW 1992 The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 37:79-87
300. Hansen TB, Brixen K, Vahl N, Jorgensen JO, Christiansen JS, Mosekilde L, Hagen C 1996 Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab 81:3352-3359
301. Jensen LT, Jorgensen JO, Risteli J, Christiansen JS, Lorenzen I 1991 Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH. Acta Endocrinol (Copenh) 124:278-282
302. Johansson AG, Lindh E, Blum WF, Kollerup G, Sorensen OH, Ljunghall S 1996 Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 81:44-48
303. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachmann M, Christiansen C 1990 Serum bone G1a protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. J Clin Endocrinol Metab 71:122-126
304. Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson BA 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81:2865-2873
305. Juul A, Pedersen SA, Sorensen S, Winkler K, Jorgensen JO, Christiansen JS, Skakkebaek NE1994 Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset. Eur J Endocrinol 131:41-49
306. Thoren M, Soop M, Degerblad M, Saaf M 1993 Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. Acta Endocrinol (Copenh) 128:41-43
307. Vandeweghe M, Taelman P, Kaufman JM 1993 Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol (Oxf) 39:409-415
308. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR 1992 Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 36:45-52
309. Wollmann HA, Schonau E, Blum WF, Meyer F, Kruse K, Ranke MB 1995 Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency. Horm Res 43:249-256
310. Bravenboer N, Holzmann P, de Boer H, Roos JC, van der Veen EA, Lips P 1997 The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men. J Clin Endocrinol Metab 82:1818-1822
311. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A 1990 A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 5:609-618
312. Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM 1990 Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70:519-527
313. Holmes S, Mawer E, Shalet S 1997 Effect of growth hormone replacement on calcium, phosphate, vitamin D and parathyroid hormone metabolism in adults with growth hormone deficiency. Endocrinol Metab 4:49-54
314. Spencer EM, Tobiassen O 1981 The mechanism of the action of growth hormone on vitamin D metabolism in the rat. Endocrinology 108:1064-1070
315. Spanos E, Barrett D, MacIntyre I, Pike JW, Safilian EF, Haussler MR 1978 Effect of growth hormone on vitamin D metabolism. Nature 273:246-247
316. Lieberman SA, Holloway L, Marcus R, Hoffman AR 1994 Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women. J Bone Miner Res 9:1723-1728
317. Degerblad M, Elgindy N, Hall K, Sjoberg HE, Thoren M 1992 Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh) 126:387-393
318. Valk NK, Erdtsieck RJ, Algra D, Lamberts SW, Pols HA 1995 Combined treatment of growth hormone and the bisphosphonate pamidronate, vs. treatment with GH alone, in GH-deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass. Clin Endocrinol (Oxf) 43:317-324
319. Holmes SJ, Whitehouse RW, Economou G, O'Halloran DJ, Adams JE, Shalet SM 1995 Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clin Endocrinol (Oxf) 42:3-7
320. Zadik Z, Chalew SA, McCarter Jr RJ, Meistas M, Kowarski AA 1985 The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 60:513-516
321. Corpas E, Harman SM, Blackman MR 1993 Human growth hormone and human aging. Endocr Rev 14:20-39
322. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Bengtsson BA 1994 Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and. Clin Endocrinol (Oxf) 41: 351-357
323. Smith Jr RW 1967 Dietary and hormonal factors in bone loss. Fed Proc 26:1737-1746
324. Boonen S, Lesaffre E, Aerssens J, Pelemans W, Dequeker J, Bouillon R 1996 Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. Gerontology 42:330-338
325. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S 1994 Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 9:915-921
326. Boonen S, Lesaffre E, Dequeker J, Aerssens J, Nijs J, Pelemans W, Bouillon R 1996 Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: potential implications for the prevention of age-related bone loss. J Am Geriatr Soc 44:1301-1306
327. Ljunghall S, Johansson AG, Burman P, Kampe O, Lindh E, Karlsson FA 1992 Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J Intern Med 232:59-64
328. Pun KK, Lau P, Wong FH, Cheng CL, Pun WK, Chow SP, Leong JC 1990 25-Hydroxycholecalciferol and insulin-like growth factor I are determinants of serum concentration of osteocalcin in elderly subjects with and without spinal fractures. Bone 11:397-400
329. Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R 1993 Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 234:249-255
330. Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, Farley JR 1994 Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging [see comments]. J Clin Endocrinol Metab 78:1011-1016
331. Kassem M, Brixen K, Blum W, Mosekilde L, Eriksen EF 1994 No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis. Eur J Endocrinol 131:150-155
332. Bennett AE, Wahner HW, Riggs BL, Hintz RL 1984 Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 59:701-704
333. Brixen K, Kassem M, Nielsen HK, Loft AG, Flyvbjerg A, Mosekilde L 1995 Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study. J Bone Miner Res 10:1865-1874
334. Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF 1994 Normal
335. Kruse HP, Kuhlencordt F 1975 On an attempt to treat primary and secondary osteoporosis with human growth hormone. Horm Metab Res 7:488-491
336. Aloia JF, Zanzi I, Ellis K, Jowsey J, Roginsky M, Wallach S, Cohn SH 1976 Effects of growth hormone in osteoporosis. J Clin Endocrinol Metab 43:992-999
337. Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH 1985 Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 34:124-129
338. Aloia JF, Vaswani A, Meunier PJ, Edouard CM, Arlot ME, Yeh JK, Cohn SH 1987 Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcif Tissue Int 40: 253-259
339. Erdtsieck RJ, Pols HA, Valk NK, van Ouwerkerk BM, Lamberts SW, Mulder P, Birkenhager JC 1995 Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial. Clin Endocrinol (Oxf) 43: 557-565
340. Holloway L, Kohlmeier L, Kent K, Marcus R 1997 Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. J Clin Endocrinol Metab 82:1111-1117
341. Ho KK, O'Sullivan AJ, Weissberger AJ, Kelly JJ 1996 Sex steroid regulation of growth hormone secretion and action. Horm Res 45:67-73
342. Ho KK, Weissberger AJ 1992 Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res 7:821-827
343. Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO 1996 Both oral and transdermal estrogen increase growth hormone release in postmenopausal women-a clinical research center study. J Clin Endocrinol Metab 81:2250-2256
344. Brown DM, Jowsey J, Bradford DS 1974 Osteoporosis in ovarian dysgenesis. J Pediatr 84:816-820
345. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ 1982 Skeletal demineralization in Turner's syndrome. Calcif Tissue Int 34:519-522
346. Bergmann P, Valsamis J, Van Perborgh J, De Schepper J, Van Vliet G 1990 Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone G1a-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone. J Clin Endocrinol Metab 71:1461-1467
347. Neely EK, Marcus R, Rosenfeld RG, Bachrach LK 1993 Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab 76:861-866
348. Lanes R, Gunczler P, Paoli M, Weisinger JR 1995 Bone mineral density of prepubertal age girls with Turner's syndrome while on growth hormone therapy. Horm Res 44:168-171
349. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1-6
350. Canalis E 1996 Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447
351. Giustina A, Bussi AR, Jacobello C, Wehrenberg WB 1995 Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J Clin Endocrinol Metab 80:122-129
352. Johansson AG, Lindh E, Ljunghall S 1992 Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet 339:1619
353. Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL 1993 Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384-1387
354. Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, Marcus R 1995 Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. J Bone Miner Res 10:1844-1852
355. Grinspoon SK, Baum HB, Peterson S, Klibanski A 1995 Effects of rhIGF-I administration on bone turnover during short-term fasting. J Clin Invest 96:900-906
356. Bagi CM, Brommage R, Deleon L, Adams S, Rosen D, Sommer A 1994 Benefit of systemically administered rhIGF-I and rhIGF-I/ IGFBP-3 on cancellous bone in ovariectomized rats. J Bone Miner Res 9:1301-1312
357. Ibbotson KJ, Orcutt CM, D'Souza SM, Paddock CL, Arthur JA, Jankowsky ML, Boyce RW 1992 Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis. J Bone Miner Res 7:425-432
358. Tobias JH, Chow JW, Chambers TJ 1992 Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats. Endocrinology 131:2387-2392
359. Cella SG, Cerri CG, Daniel S, Sibilia V, Rigamonti A, Cattaneo L, Deghenghi R, Muller EE 1996 Sixteen weeks of hexarelin therapy in aged dogs: effects on the somatotropic axis, muscle morphology, and bone metabolism. J Gerontol 51:B439-B447